DSM Signs Supply Agreement with IEP
DSM Pharma Chemicals (Parsippany, NJ), a business unit of DSM Pharmaceutical Products, entered into an enzyme- supply agreement
with IEP (Wiesbaden, Germany) to enable fast and secure scale-up of chiral alcohol manufacturing. Under the terms of the agreement,
DSM Pharma Chemicals has access to IEP's alcohol dehydrogenases, as well as a supply of IEP enzymes at commercial scale. DSM
can source the enzymes from IEP or produce them in its own manufacturing facilities in Delft, The Netherlands, Capua, Italy,
and Seclin, France. According to Oliver May, DSM's competence manager for biocatalysis, a flexible enzyme supply chain is
key to the timely delivery of products to DSM's customers.
Akrimax Purchases Wyeth Plant
Akrimax Pharmaceuticals (Cranford, NJ) acquired Wyeth's (Madison, NJ) drug-product manufacturing and packaging plant in Rouses
Point, New York. The acquisition prevents the plant's closure. Wyeth had planned to phase out its operations at the Rouses
Point plant because of changes in product demand and a reassessment of its manufacturing network.
Akrimax is an emerging branded-pharmaceutical company led by a management team with expertise in the development, manufacturing,
distribution, marketing, and sales of pharmaceutical products.